What's new

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 20, Status: Authorised

Apr 9, 2025 - 15:19
 0
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

QRD Appendix V - Adverse-drug-reaction reporting details

Next Article

Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of ...

Related Posts

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Maximum residue limits (MRL)

Maximum residue limits (MRL)

Feb 18, 2025  0

Mandate, objectives and rules of procedure for the CVMP...

Mar 21, 2025  0